PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Ensysce Biosciences, Inc.
Filed: May 15, 2020
Period of Report: May 14, 2020
Accession Number: 0001213900-20-012654

View Document ↗ View on SEC.gov ↗